ADVENTRX Completes Acquisition of SynthRx
ADVENTRX and SynthRx, a private biotechnology company, completed a definitive merger on April 8, 2011.
feature2
CeQur Develops Diabetes Compliance Device
An important drawback of current diabetes treatment regimens is patient compliance, particularly for insulin injections that are painful and must also be timely administered.
Accord Biosciences To Present At OneMedForum NY 2011
Nitric oxide is one of the most important physiological signaling molecules in the body, responsible for regulating such fundamental biological processes as proper blood vessel function and the body’s defense against infection.
Del Mar Pharmaceuticals Is Fighting Cancer One Molecule At A Time
Del Mar Pharmaceuticals was recently added to the roster of presenting companies at OneMedForum NY 2011.
MEDomics to Present At OneMedForum NY 2011
OneMedForum NY 2011 welcomes MEDomics, LLC, a molecular diagnostic laboratory, confirmed to present in June at the annual conference.
Aduro Biotech, OneMedForum SF Presenting Company, Announces $20 Million Financing
Aduro BioTech, a OneMedForum presenting company is engineering Listeria to treat Pancreatic Cancer and other infectious diseases.
New Software From iCAD Helps Doctors Diagnose Prostate Cancer
New software being used at Englewood Hospital and Medical Center should help detect prostate cancer earlier, eliminate unnecessary testing procedures and help form a treatment plan.
OneMedForum NY 2011 Grows Its Advisory Board And Selects Initial Presenters
OneMedForum NY 2011, to be held June 23 -24, has added new members to the Advisory Board and selected an initial group of “discovery” lesser known companies with terrific growth potential.
ThermoGenesis to Begin Sale of Novel Stem Cell Device in India
ThermoGenesis said its device, used in processing stem cells from bone marrow, got Indian marketing approval, sending its shares up as much as 8 percent.
Taris Biomedical Closes $18.3 Million Financing
Taris Biomedical completes an $18.3 million B round that the company says will support the clinical development of its bladder disorder treatment drug-device combination.